RSS feed (help and list of feeds)
Annual Review
Our new information sheets, referred to in our 2008 Annual Review, are available here.
- Annual Review 2011 (36 pages, 1587 KB) 13 Dec 2011
- Annual Review 2010 (30 pages, 1954 KB) 15 Dec 2010
- Annual Review 2009 (34 pages, 2309 KB) 01 Jan 2009
- Annual Review 2008 (32 pages, 5227 KB) 01 Jan 2008
- Annual Review 2007 (32 pages, 2666 KB) 01 Jan 2007
- Annual Review 2006 (32 pages, 7116 KB) 24 Nov 2006
- Annual Review 2005 (28 pages, 6467 KB) 10 Nov 2005
- Annual Review 2004 (28 pages, 1445 KB) 28 Oct 2004
- Annual Review 2003 (32 pages, 887 KB) 11 Nov 2003
- Annual Review 2002 (28 pages, 1059 KB) 04 Nov 2002
- Annual Review 2001 (31 pages, 944 KB) 01 Oct 2001
- Annual Review 2000 (31 pages, 1176 KB) 17 Oct 2000
- Annual Review 1999 (31 pages, 746 KB) 14 Dec 1999
- Annual Review 1998 (29 pages, 1209 KB) 02 Oct 1998
- Annual Review 1997 (26 pages, 987 KB) 01 Jan 1997
- Annual Review 1996 (27 pages, 12887 KB) 01 Jan 1996
- Annual Review 1995 (23 pages, 9739 KB) 01 Jan 1995
- PHARMAC - the first 20 months (26 pages, 8345 KB) 01 Dec 1994
Page updated on 10 May 2012
Linked documents
Annual Review 2011 (36 pages, 1587 KB)
Pharmaceutical Management Agency Annual Review 2011 2010 /11 Highlights > Pharmaceutical spending managed on budget - $706.1 million compared to a budget of $710 million (budget includes DHB allocation of $700 million and up to $10 million from PHARMAC’s Discretionary…
Annual Review 2010 (30 pages, 1954 KB)
Pharmaceutical Management Agency Annual Review 2010 2 2009 /10 Highlights • Community pharmaceutical spending managed on budget - $693.8 million compared to a budget of $694 million • 20 new medicines funded and access widened to 25 others • New…
Annual Review 2009 (34 pages, 2309 KB)
Pharmaceutical Management Agency Annual Review 2009 Highlights of 2008/09 2 During 2008/9 we: > Hit the budget target of $653 million > Added eight new medicines to the Pharmaceutical Schedule, and widened access to 55. New medicines include treatments for…
Annual Review 2008 (32 pages, 5227 KB)
Front Cover Pharmaceutical Management Agency Annual Review 2008 The PHARMAC decision making process The process set out in this diagram is intended to be indicative of the process that may follow where a supplier or other applicant wishes a pharmaceutical…
Annual Review 2007 (32 pages, 2666 KB)
Pharmaceutical Management Agency Annual Review 2007 Front Cover PHARMAC annual review Highlights & key events of 006-07 We funded 11 new medicines, and made 39 new investments in medicine 3 At least .69 million people had their medicine subsidised Subsidised…
Annual Review 2006 (32 pages, 7116 KB)
PHARMAC invested in health by providing new or expanded access to 41 subsidised treatments New investments include treatments for cardiovascular risk, schizophrenia, rheumatoid arthritis, osteoporosis, hepatitis, Parkinson’s disease, multiple…
Annual Review 2002 (28 pages, 1059 KB)
Major PHARMAC achievements in 2001-02 were: Providing new or wider access to 24 subsidised treatments, including those for raised cholesterol, multiple sclerosis, schizophrenia, epilepsy, arthritis and hay fever under cost-neutral and/or financially sustainable arrangements. Containing pharmaceutical expenditure growth by successfully negotiating savings worth approximately $36.8 million...
Annual Review 1999 (31 pages, 746 KB)
R Annual evıew for the year ended 30 June 1999 P H A R M AC (the Pharmaceutical Management Agency Ltd) is a not-for-profit company owned by the Health Funding Authority (HFA). Its role is to manage the national Pharmaceutical…
Annual Review 1996 (27 pages, 12887 KB)
PHARMAC 611 Pharmaceutical Management Agency Ltd The balloon' why it lIt The co a Wl PH A R M AC (pharmaceutical Management Agency Limited) was established in mid-1993 to manage the national Pharmaceutical Schedule on behalf of the four RHAs…
Annual Review 1995 (23 pages, 9739 KB)
PHARMAC III Pharmaceutical Management Agency Ltd for the year ended 30 June Treating more patients. Slowing budget growth. PHARMAC (Pharmaceutical Management Agency Limited) was established in mid-1993 to manage the national Pharmaceutical Schedule on behalf of the four RHAs (Regional…
PHARMAC - the first 20 months (26 pages, 8345 KB)
PHARMAC III Pharmaceutical Management Agency Ltd PHARMAC the first 20 months measured responsible decisions PHARMAC the first 20 months PHARMAC manages the subsidisation of pharmaceuticals for the benefit of all New Zealanders. PHARMAC makes decisions that involve: Rational, scientific evaluation…
